GSK plc Announces Share Buyback Transaction on 16 October 2025

GSK plc, acting through BNP Paribas SA, purchased 310,000 of its ordinary shares on 16 October 2025 as part of its existing buyback programme. The shares were bought at prices ranging from 1,621.50p to 1,637.00p, with a volume-weighted average price of 1,629.84p. The purchased shares will be held as treasury shares. Following this transaction, GSK plc holds 251,694,344 ordinary shares in treasury and has 4,063,719,485 ordinary shares in issue, excluding treasury shares. The total number of voting rights in the company is 4,063,719,485, with 6.19% of voting rights attributable to the treasury shares. This buyback is in line with the non-discretionary agreement announced on 30 September 2025, under which GSK has purchased a total of 4,229,500 ordinary shares since that date.